1. Liu, Jun-Feng, Zou, Bing, Xiang, Cheng, Yan, Hai-Chao. 2024. Comprehensive bioinformatics analysis unveils THEMIS2 as a carcinogenic indicator related to immune infiltration and prognosis of thyroid cancer. In Scientific reports, 14, 8156. doi:10.1038/s41598-024-58943-6. https://pubmed.ncbi.nlm.nih.gov/38589421/
2. Yao, Jiyou, Hua, Xuefeng, Shi, Jiewei, Lan, Tian, Lu, Minqiang. . LncRNA THEMIS2-211, a tumor-originated circulating exosomal biomarker, promotes the growth and metastasis of hepatocellular carcinoma by functioning as a competing endogenous RNA. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 36, e22238. doi:10.1096/fj.202101564R. https://pubmed.ncbi.nlm.nih.gov/35224785/
3. Hartweger, Harald, Schweighoffer, Edina, Davidson, Sophia, Wack, Andreas, Tybulewicz, Victor L J. 2014. Themis2 is not required for B cell development, activation, and antibody responses. In Journal of immunology (Baltimore, Md. : 1950), 193, 700-7. doi:10.4049/jimmunol.1400943. https://pubmed.ncbi.nlm.nih.gov/24907343/
4. Huang, Wei-Chieh, Yen, Jia-Hau, Sung, Yu-Wen, Huang, Shih-Jei, Wang, Lu-Hai. 2022. Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET. In Oncogene, 41, 997-1010. doi:10.1038/s41388-021-02136-2. https://pubmed.ncbi.nlm.nih.gov/34974522/
5. Gao, Yang, Qi, Yuwen, Shen, Yin, Wang, Hua, Cai, Hongbing. 2024. Signatures of tumor-associated macrophages correlate with treatment response in ovarian cancer patients. In Aging, 16, 207-225. doi:10.18632/aging.205362. https://pubmed.ncbi.nlm.nih.gov/38175687/
6. Guo, Yiwen, Zhang, Yixi, Yu, Jia, Ju, Weiqiang, Chen, Maogen. 2023. Novel ceRNA network construction associated with programmed cell death in acute rejection of heart allograft in mice. In Frontiers in immunology, 14, 1184409. doi:10.3389/fimmu.2023.1184409. https://pubmed.ncbi.nlm.nih.gov/37753085/
7. Xing, Xuewu, Xia, Qun, Gong, Baoqi, Shen, Zhongyang, Zhang, Yingze. 2022. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis. In Frontiers in genetics, 13, 855557. doi:10.3389/fgene.2022.855557. https://pubmed.ncbi.nlm.nih.gov/35368701/
8. Zhang, Qiying, Zhang, Jing, Liu, Zi, Su, Jin, Zhao, Yalong. 2023. Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy. In Drug design, development and therapy, 17, 3507-3522. doi:10.2147/DDDT.S429180. https://pubmed.ncbi.nlm.nih.gov/38046281/
9. Guo, Qingbao, Fan, Yan-Na, Xie, Manli, Bao, Xiangyang, Duan, Lian. 2024. Exploring the transcriptomic landscape of moyamoya disease and systemic lupus erythematosus: insights into crosstalk genes and immune relationships. In Frontiers in immunology, 15, 1456392. doi:10.3389/fimmu.2024.1456392. https://pubmed.ncbi.nlm.nih.gov/39290707/
智鼠故事 
